Rayner Announces New Appointments to Management Board

Rayner announced three new appointments to its management board. James Crutchlow has been appointed Chief Commercial Officer; Rob Nadler was named Chief Growth Officer; and Chris Willis was named Chief Marketing Officer, effective immediately.

“This important change will help us to maintain our track record of innovation and ensure the company remains agile and focused on ophthalmologists.” Rayner CEO Tim Clover said in a company news release. “James, Rob and Chris each bring a breadth of experience both at Rayner and in the wider industry which will be pivotal in our continued growth.”

Mr. Crutchlow joined Rayner in 2008, and has served as Vice President Europe, leading commercial execution, launching Rayner’s product pipeline and expanding its presence to new markets. In his new role as Chief Commercial Officer, Mr. Crutchlow will lead a single global commercial group.

Dr. Rob Nadler has 18 years of experience in investment banking and is a qualified ophthalmologist. He has been with Rayner for 3 years leading corporate development. With a focus on R&D, corporate development and M&A for Rayner, Dr. Nadler will lead a newly created growth team.

Mr. Willis has served 3 years as Vice President Marketing at Rayner, and has over 20 years in the ophthalmology industry. As Chief Marketing Officer, Mr. Willis will lead marketing, eye science and digital healthcare.